CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Alpha Network Alliance Ventures Inc.  (ANAV)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ANAV's Revenue Growth by Quarter and Year

Alpha Network Alliance Ventures's Revenue results by quarter and year




ANAV Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter September - - - 0.01
III Quarter June 0.05 - 0.01 0.04
II Quarter March 0.03 - 0.01 0.01
I Quarter December 0.07 0.03 - 0.05
FY   0.15 0.03 0.02 0.11



ANAV Revenue third quarter 2018 Y/Y Growth Comment
Alpha Network Alliance Ventures Inc. in the third quarter achieved Revenue of $ 0.05 millions compare to recorded in same quarter a year ago.

Looking into third quarter results within Biotechnology & Drugs industry 2 other companies have achieved higher Revenue growth. While Alpha Network Alliance Ventures Inc.' s Revenue no change of % ranks overall at the positon no. 415 in the third quarter.




ANAV Revenue ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter September - - - -
III Quarter June - - -75 % -
II Quarter March - - 0 % -
I Quarter December 133.33 % - - -54.55 %
FY   - 50 % -81.82 % -

Financial Statements
Alpha Network Alliance Ventures's third quarter 2018 Revenue $ 0.00 millions ANAV's Income Statement
Alpha Network Alliance Ventures's third quarter 2017 Revenue $ 0.00 millions Quarterly ANAV's Income Statement
New: More ANAV's historic Revenue Growth >>


ANAV Revenue (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter September - - - -75 %
III Quarter June 72.98 % - 0 % 300 %
II Quarter March -57.14 % - - -80 %
I Quarter December - - - -
FY (Year on Year)   - 50 % -81.82 % -




Revenue third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #3
Healthcare Sector #38
Overall #415

Revenue Y/Y Growth Statistics
High Average Low
122.12 % 6.46 % -44.82 %
(Dec 31 2017)   (Dec. 30, 2015)
Revenue third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #3
Healthcare Sector #38
Overall #415
Revenue Y/Y Growth Statistics
High Average Low
122.12 % 6.46 % -44.82 %
(Dec 31 2017)   (Dec. 30, 2015)

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Alpha Network Alliance Ventures's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
1980.57 % 198.8 % -100 %
(Dec 31 2017)  


ANAV's III. Quarter Q/Q Revenue Comment
Alpha Network Alliance Ventures Inc. achieved in the III. Quarter 2018 below company average Revenue jump of 72.98% quarter on quarter, to $ 0.05 millions.

Even if the III. Quarter 2018 results were below the average of 198.8 %, that was still good story, as the III. Quarter improvement, outshines the % growth in the same quarter a year ago

Within Biotechnology & Drugs industry 103 other companies have achieved higher Revenue quarter on quarter growth. While Alpha Network Alliance Ventures's Revenue growth quarter on quarter, overall rank is 3755.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #104
Healthcare Sector #494
Overall #3755
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #104
Healthcare Sector #494
Overall #3755
Revenue Q/Q Growth Statistics
High Average Low
1980.57 % 198.8 % -100 %
(Dec 31 2017)  


ANAV's III. Quarter Q/Q Revenue Comment
Alpha Network Alliance Ventures Inc. achieved in the III. Quarter 2018 below company average Revenue jump of 72.98% quarter on quarter, to $ 0.05 millions.

Even if the III. Quarter 2018 Alpha Network Alliance Ventures's performance was lower than the regular of 198.8 %, it has been still promising sign, as the III. Quarter surge, transcends the % growth in the III. Quarter 2017

Within Biotechnology & Drugs industry 103 other companies have achieved higher Revenue quarter on quarter growth. While Alpha Network Alliance Ventures's Revenue growth quarter on quarter, overall rank is 3755.


Alpha Network Alliance Ventures's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
12 Months Ending
(Jun 30 2017)
Cumulative Revenue 12 Months Ending $ 0.16 $ 0.11 $ 0.08 $ 0.04 $ 0.04
Y / Y Revenue Growth (TTM) 326.83 % 134.57 % 41.38 % 9.07 % -7.45 %
Year on Year Revenue Growth Overall Ranking # 67 # 173 # 523 # 1528 # 67
Seqeuential Revenue Change (TTM) 42.21 % 35.16 % 122.12 % -0.02 % -21.85 %
Seq. Revenue Growth (TTM) Overall Ranking # 444 # 122 # 120 # 2817 # 112




Cumulative Revenue growth Comment
With 326.83% annual Revenue growth, Alpha Network Alliance Ventures Inc. would report a record annual Revenue surge if the fiscal year would end on Jun 30 2018.

Among companies within the Healthcare sector 17 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 67, from total ranking in previous quarter at 173.

Revenue TTM Q/Q Growth Statistics
High Average Low
122.12 %
6.46 %
-44.82 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 28
Healthcare Sector # 18
Overall # 67

Revenue TTM Y/Y Growth Statistics
High Average Low
326.83 %
52.36 %
-66.36 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 118
S&P 500 # 444
Cumulative Revenue growth Comment
With 326.83% annual Revenue growth, Alpha Network Alliance Ventures Inc. would report a record annual Revenue surge if the fiscal year would end on Jun 30 2018.

Among companies within the Healthcare sector 17 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 67, from total ranking in previous quarter at 173.

Revenue TTM Q/Q Growth Statistics
High Average Low
122.12 %
6.46 %
-44.82 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 28
Healthcare Sector # 18
Overall # 67

Revenue TTM Y/Y Growth Statistics
High Average Low
326.83 %
52.36 %
-66.36 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 118
S&P 500 # 444




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ANAV's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ANAV's Competitors
Revenue Growth for Alpha Network Alliance Ventures's Suppliers
Revenue Growth for ANAV's Customers

You may also want to know
ANAV's Annual Growth Rates ANAV's Profitability Ratios ANAV's Asset Turnover Ratio ANAV's Dividend Growth
ANAV's Roe ANAV's Valuation Ratios ANAV's Financial Strength Ratios ANAV's Dividend Payout Ratio
ANAV's Roa ANAV's Inventory Turnover Ratio ANAV's Growth Rates ANAV's Dividend Comparisons



Companies with similar Revenue surge for the quarter ending Jun 30 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2018
United Therapeutics Corp -0.02 %$ -0.022 millions
Tg Therapeutics, Inc. -0.25 %$ -0.249 millions
Pacific Health Care Organization Inc -0.84 %$ -0.843 millions
Prestige Consumer Healthcare Inc. -1.01 %$ -1.011 millions
Edap Tms Sa -1.29 %$ -1.295 millions
Jaguar Health, Inc. -1.41 %$ -1.414 millions
Regenerx Biopharmaceuticals Inc -1.59 %$ -1.590 millions
Capital Senior Living Corp -1.79 %$ -1.791 millions
Vycor Medical Inc -1.96 %$ -1.956 millions
Five Star Senior Living Inc. -1.98 %$ -1.979 millions
Rti Surgical, Inc. -1.99 %$ -1.990 millions
Retractable Technologies Inc -2.24 %$ -2.238 millions
Icad Inc -2.26 %$ -2.262 millions
Hca Healthcare, Inc. -2.35 %$ -2.346 millions
Brookdale Senior Living Inc. -2.64 %$ -2.636 millions
Vitality Biopharma, Inc. -2.64 %$ -2.644 millions
Biolase, Inc -3.63 %$ -3.631 millions
Milestone Scientific Inc. -3.77 %$ -3.774 millions
Akorn Inc -4.12 %$ -4.116 millions
Radnet, Inc. -4.61 %$ -4.608 millions
Bausch Health Companies Inc. -4.70 %$ -4.702 millions
Aratana Therapeutics, Inc. -4.85 %$ -4.847 millions
Escalon Medical Corp. -4.86 %$ -4.858 millions
Vet Online Supply Inc -5.28 %$ -5.278 millions
Corium International, Inc. -5.41 %$ -5.414 millions
Amag Pharmaceuticals Inc. -7.66 %$ -7.664 millions
Endologix Inc -7.86 %$ -7.859 millions
Windtree Therapeutics Inc -8.37 %$ -8.370 millions
Tearlab Corp -8.57 %$ -8.569 millions
Procyon Corp -8.57 %$ -8.573 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LUNG's Profile

Stock Price

LUNG's Financials

Business Description

Fundamentals

Charts & Quotes

LUNG's News

Suppliers

LUNG's Competitors

Customers & Markets

Economic Indicators

LUNG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071